Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
GNC-035 by Systimmune for Non-Hodgkin Lymphoma: Likelihood of Approval
GNC-035 is under clinical development by Systimmune and currently in Phase II for Non-Hodgkin Lymphoma. According to GlobalData, Phase II...